January 24, 2025 - 00:14

In a significant move, President Trump has signed an executive order to withdraw the United States from the World Health Organization (WHO), an organization that has relied heavily on US funding. As the largest contributor to the WHO, the US exit raises concerns about the future of global health initiatives and pandemic preparedness.
The decision to leave the WHO comes amid ongoing debates about the organization's handling of the COVID-19 pandemic. Critics argue that the withdrawal could undermine international efforts to combat diseases and share vital health information. With the US stepping back, there are fears that funding gaps may hinder research and response capabilities, especially in low-income countries that depend on WHO support.
Moreover, the departure may lead to a fragmented global health landscape, as cooperation between nations becomes more challenging. Experts warn that without strong leadership and collaboration, the world may struggle to effectively respond to future health crises, ultimately putting millions of lives at risk. The long-term effects of this withdrawal will likely resonate across the globe for years to come.
November 1, 2025 - 03:51
Tammy Derk Appointed Vice President of Children's Services at Penn State HealthPenn State Health has appointed Tammy Derk as the new administrative vice president of its Children’s services, marking a significant leadership change within the organization. With over 30 years...
October 31, 2025 - 01:14
Honoring the Champions of Public HealthAt the 2025 Awards Gala and Silent Auction, the National Foundation for Infectious Diseases celebrated the remarkable contributions of three distinguished public health champions: Anne E. Goldfeld,...
October 30, 2025 - 08:19
Major Reductions in Federal Mental Health and Addiction Agency Under Trump AdministrationThe Trump administration has significantly diminished the federal agency responsible for mental health and addiction treatment, leading to a reduction of its workforce by over 50%. This drastic cut...
October 29, 2025 - 18:25
Federal Regulators Aim to Lower Costs of Biotech MedicationsFederal regulators are taking significant steps to facilitate the development of more affordable alternatives to essential biotech drugs that millions of Americans rely on for treating serious...